Dr. Stephen Hahn Nominated to Head FDA
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
CRC Screening Recommended for Average-Risk Adults Age 50 to 75
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Seriously Ill Medicare Beneficiaries Face Financial Hardship
Majority of respondents rely on help from family and friends, at considerable cost
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
2007 to 2016 Saw Rise in ADHD Prevalence in Adults, Children
Increase seen for adults of every race/ethnicity; prevalence rates highest for white individuals
Risk for Second Primary Malignancy Up in CLL Survivors
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
Risk for Birth Defects Not Increased With Adalimumab
Risk for preterm delivery higher in women with RA, Crohn disease regardless of adalimumab exposure
Equivalence Seen Between Drug Classes for HTN Monotherapy
Thiazide, thiazide-like diuretics superior to ACEi; nondihydropyridine calcium channel blockers inferior
Borderline Personality Disorder May Raise Cardiometabolic Risk
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk
Increase Seen in Opioid-, Synthetic Opioid-Involved OD Deaths
From 2015 to 2017, number of opioid-involved overdose deaths increased for nearly all racial/ethnic groups
